Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plecanatide in Adolescents with Chronic Idiopathic Constipation
NCT03120520Phase 2Completed
- Sponsor
- Valeant Pharmaceuticals
- Start
- Jan 2017
- Primary completion
- Sep 2018
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of plecanatide in chronic idiopathic constipation (CIC) (4 arms), sponsored by Valeant Pharmaceuticals. Primary endpoint: Proportion of Overall Responders at 8 weeks. Started Jan 2017; status: completed.
02
Drugs
plecanatide
03
Conditions
chronic idiopathic constipation (CIC)
Beyond the preview
Go deeper on NCT03120520.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03120520.